Celldex Therapeutics (NASDAQ:CLDX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you’ll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Analysts have set 12-month price targets for Celldex Therapeutics, revealing an average target of $77.4, a high estimate of $80.00, and a low estimate of $67.00. A 3.25% drop is evident in the current average compared to the previous average price target of $80.00. Exploring Analyst R…